JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4660 PI-3065

Target: PI3K

Summary: P110δkinase inhibitor

≥22.7 mg/mL
B5246 740 Y-P
5 Citation

Target: PI3K

Summary: PI 3-kinase activator,cell permeable

≥163.54 mg/mL
A3005 CAL-101 (Idelalisib, GS-1101)
2 Citation

Target: PI3K

Summary: PI3K inhibitor
A3015 BKM120
1 Citation

Target: PI3K

Summary: Inhibitor of pan-Class I PI3K

≥20.52 mg/mL
A4097 CUDC-907

Target: Histone Deacetylases (HDACs)|PI3K

Summary: Potent PI3K/HDAC inhibitor

≥25.45 mg/mL
A3927 VS-5584 (SB2343)

Target: PI3K|mTOR

Summary: MTOR/P13K inhibitor,potent and selective

insoluble in H2O; ≥17.7 mg/mL
B2186 GSK2636771

Target: PI3K

Summary: PIK3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.83 mg/mL
B2178 BAY 80-6946 (Copanlisib)
1 Citation

Target: PI3K

Summary: PI3K inhibitor

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
B2180 AS-252424

Target: Akt|PI3K

Summary: PI3Kγ inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥30.5 mg/mL
B1371 Miltefosine

Target: PI3K

Summary: PI3K/Akt inhibitor

≥10.2 mg/mL